[go: up one dir, main page]

PH12012501200A1 - Therapeutic combinations of theobromine and an antihistamine - Google Patents

Therapeutic combinations of theobromine and an antihistamine

Info

Publication number
PH12012501200A1
PH12012501200A1 PH1/2012/501200A PH12012501200A PH12012501200A1 PH 12012501200 A1 PH12012501200 A1 PH 12012501200A1 PH 12012501200 A PH12012501200 A PH 12012501200A PH 12012501200 A1 PH12012501200 A1 PH 12012501200A1
Authority
PH
Philippines
Prior art keywords
antihistamine
theobromine
therapeutic combinations
therapy
therapeutic
Prior art date
Application number
PH1/2012/501200A
Inventor
Robin Mark Bannister
John Brew
Original Assignee
Biocopea Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocopea Ltd filed Critical Biocopea Ltd
Publication of PH12012501200A1 publication Critical patent/PH12012501200A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

An agent comprises theobromine and an antihistamine, as a combined preparation for simultaneous, sequential or separate use in therapy, particularly in the therapy of cough.
PH1/2012/501200A 2009-12-14 2010-12-14 Therapeutic combinations of theobromine and an antihistamine PH12012501200A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0921803.3A GB0921803D0 (en) 2009-12-14 2009-12-14 Drug composition and its use in therapy
PCT/GB2010/052086 WO2011073647A1 (en) 2009-12-14 2010-12-14 Therapeutic combinations of theobromine and an antihistamine

Publications (1)

Publication Number Publication Date
PH12012501200A1 true PH12012501200A1 (en) 2012-11-26

Family

ID=41667043

Family Applications (1)

Application Number Title Priority Date Filing Date
PH1/2012/501200A PH12012501200A1 (en) 2009-12-14 2010-12-14 Therapeutic combinations of theobromine and an antihistamine

Country Status (18)

Country Link
EP (1) EP2512472A1 (en)
JP (2) JP2013513652A (en)
CN (1) CN102802625A (en)
AU (1) AU2010332495C1 (en)
BR (1) BR112012014159A8 (en)
CA (1) CA2784215A1 (en)
CO (1) CO6541638A2 (en)
GB (1) GB0921803D0 (en)
IL (1) IL220384A0 (en)
MX (1) MX2012006624A (en)
NZ (1) NZ600267A (en)
PE (1) PE20121538A1 (en)
PH (1) PH12012501200A1 (en)
RU (1) RU2012129675A (en)
SG (2) SG181603A1 (en)
UA (1) UA105827C2 (en)
WO (1) WO2011073647A1 (en)
ZA (1) ZA201204294B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB201111485D0 (en) * 2011-07-05 2011-08-17 Biocopea Ltd Drug composition and its use in therapy
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
CN103263533B (en) * 2013-05-31 2014-11-05 杨宏伟 Theobromine composition for treating cough and application and preparation thereof
CN104188998A (en) * 2014-09-18 2014-12-10 中山大学 Naringin and fexofenadine hydrochloride drug composition and preparation thereof
CN104224819B (en) * 2014-09-18 2016-08-17 中山大学 A kind of naringin and levo-cetirizine hydrochloride pharmaceutical composition and preparation thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE59550T1 (en) * 1986-04-17 1991-01-15 Alza Corp CHLORPHENIRAMINE THERAPY.
HUP9700654A2 (en) 1997-03-26 1999-09-28 Dezső Korbonits Antitussive compositions containing theobromine
JPH10316568A (en) * 1997-05-13 1998-12-02 Taisho Pharmaceut Co Ltd Pharmaceutical composition
JP2003012514A (en) * 2001-07-02 2003-01-15 Taisho Pharmaceut Co Ltd Pharmaceutical composition
JP2003128549A (en) * 2001-08-15 2003-05-08 Rohto Pharmaceut Co Ltd Composition applicable to mucous membrane
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
US20080254029A1 (en) * 2007-04-11 2008-10-16 Alcon Research, Ltd. Use of an Inhibitor of TNFa Plus an Antihistamine to Treat Allergic Rhinitis and Allergic Conjunctivitis

Also Published As

Publication number Publication date
PE20121538A1 (en) 2012-12-21
CA2784215A1 (en) 2011-06-23
NZ600267A (en) 2013-07-26
IL220384A0 (en) 2012-08-30
WO2011073647A1 (en) 2011-06-23
RU2012129675A (en) 2014-01-27
SG10201408374WA (en) 2015-01-29
JP6078605B2 (en) 2017-02-08
AU2010332495B2 (en) 2015-01-22
UA105827C2 (en) 2014-06-25
JP2013513652A (en) 2013-04-22
AU2010332495A1 (en) 2012-06-21
CO6541638A2 (en) 2012-10-16
JP2016040280A (en) 2016-03-24
BR112012014159A2 (en) 2017-08-29
EP2512472A1 (en) 2012-10-24
AU2010332495C1 (en) 2016-02-11
GB0921803D0 (en) 2010-01-27
MX2012006624A (en) 2012-10-05
BR112012014159A8 (en) 2017-12-26
CN102802625A (en) 2012-11-28
SG181603A1 (en) 2012-07-30
ZA201204294B (en) 2013-02-27

Similar Documents

Publication Publication Date Title
PH12012501200A1 (en) Therapeutic combinations of theobromine and an antihistamine
TN2013000508A1 (en) Combination therapy comprising a cdk4/6 inhibitor and a pi3k inhibitor for use in the treatment of cancer
IL210802A0 (en) Purin derivatives for use in the treatment of fab-related diseases
AP2012006339A0 (en) Methods of administering pirfenidone therapy.
TN2012000414A1 (en) Forms of rifaximin and uses thereof
ZA201000075B (en) Purin derivatives for use in the treatment of fab-related diseases
EP4364796A3 (en) Use of linagliptin in cardio- and renoprotective antidiabetic therapy
MX356801B (en) Increasing drug bioavailability in naltrexone therapy.
IL218182A0 (en) Kinase inhibitors, prodrug forms thereof and their use in therapy
PH12013500392A1 (en) Theobromine in combination with an expectorant or a mucolytic for use in therapy
IL215363A0 (en) Combination therapy using an anti-egfr agent(s) and igf-1r specific inhibitors
PH12012501369A1 (en) Drug combination with theobromine and its use in therapy
PH12012501203A1 (en) Combination of theobromine with a decongestant and its use for the treatment of cough
PH12012500955A1 (en) Drug combination with theobromine and its use in therapy
TW200631584A (en) A medicament related to mirtazapine for the treatment of hot flush
PL2477990T3 (en) 5-phenyl pyrazolopyridine derivatives, preparation and therapeutic use thereof
UA70710U (en) Method for preventing recurrence of allergodermatosis in patients with secondary immunodeficiencies
ECSP12011969A (en) THERAPEUTIC COMBINATIONS OF THEOBROMINE AND AN ANTIHISTAMINE
UA43276U (en) Chuprykov-tarshynov method for treating hyperactivity in children
HK1161554A (en) Combination therapy using an anti-egfr agent(s) and igf-1r specific inhibitors
UA57852U (en) Method for treating recurrent forms of allergodermatosis in patients with secondary immunodeficiency
TN2010000464A1 (en) Dronedarone for the prevention of cardioversion
HK1166787A (en) Jak2 inhibitors and their use for the treatment of myeloproliferative diseases and cancer
HK1175172A (en) Pyridine-pyridinone derivatives, preparation and therapeutic use thereof
AU2009900783A0 (en) Therapeutic and diagnostic agents